Macroporous poly(vinyl alcohol) microspheres bearing phosphate groups as a new adsorbent for low-density lipoprotein apheresis

Biomedical Materials

Volumn 4, Issue 6, 2009, Pages

  Wang, Weichao ^a   Xie, Hui ^a   Sun, Lisha ^b   Ou, Lailiang ^a   Wang, Lianyong ^a   Yu, Yaoting ^a   Kong, Deling ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FREE RADICAL POLYMERIZATION; IONIC STRENGTH; LIPIDS; MICROSPHERES; ORGANIC POLYMERS; PHOSPHORUS; PLASMAS; POLYVINYL ACETATES; PROTEINS; SODIUM; THERMAL CONDUCTIVITY;

ADSORPTION CAPACITIES; ADSORPTION TIME; BLOOD PERFUSION; HIGH-DENSITY LIPOPROTEINS; HYDROLYSIS REACTION; HYPERLIPIDEMIA; IN-VITRO; IN-VIVO EXPERIMENTS; LOW DENSITY LIPOPROTEINS; MACROPOROUS; OXYCHLORIDES; PHOSPHATE GROUP; PLASMA LIPOPROTEINS; PLASMA VOLUME; PREPARATION CONDITIONS; REACTION TIME; STORAGE TESTS; SUSPENSION POLYMERIZATION; TRIALLYL ISOCYANURATE; VINYL ACETATES;

ADSORPTION;

ADSORBENT; CHOLESTEROL; COPOLYMER; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; METHANOL; MICROSPHERE; POLYVINYL ALCOHOL; SODIUM HYDROXIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VINYL ACETATE TRIALLYL ISOCYANURATE COPOLYMER; FREE RADICAL; LIGAND; PHOSPHATE; PHOSPHORUS DERIVATIVE; PHOSPHORUS OXYCHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APHERESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; HYDROLYSIS; HYPERLIPIDEMIA; IONIC STRENGTH; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PLASMA VOLUME; POLYMERIZATION; RABBIT; TEMPERATURE; TRIACYLGLYCEROL BLOOD LEVEL; ADSORPTION; ANIMAL; CHEMICAL MODEL; CHEMISTRY; INSTRUMENTATION; METABOLISM; PERFUSION; POROSITY;

ORYCTOLAGUS CUNICULUS;

ADSORPTION; ANIMALS; BLOOD COMPONENT REMOVAL; FREE RADICALS; HYPERLIPIDEMIAS; LIGANDS; LIPOPROTEINS, LDL; MICROSPHERES; MODELS, CHEMICAL; PERFUSION; PHOSPHATES; PHOSPHORUS COMPOUNDS; POLYVINYL ALCOHOL; POROSITY; RABBITS;

EID: 76649123631     PISSN: 17486041     EISSN: 1748605X     Source Type: Journal    
DOI: 10.1088/1748-6041/4/6/065007     Document Type: Article

References (36)

1. Kannel W B, et al. 1971 Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham study Ann. Int. Med. 74 1-12
2. Pekkanen J, et al. 1990 Ten year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease N. Engl. J. Med. 322 1700-7
3. Tatami R, et al. 1992 Regression of coronary atherosclerosis by combined LDL-hemoperfusion and lipid-lowing drugs therapy in patients with familial hypercholesterolemia: a multicenter study Atherosclerosis 95 1-13
4. Frantz I D Jr, et al. The Minnesota Coronary Survey 1989 Test of effect of lipid lowering by diet on cardiovascular risk Arteriosclerosis 9 129-35
5. Pignone M, Phillips C and Mulrow C 2000 Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials BMJ 321 983-6
6. Thompson G R, Lowental R and Myant N B 1975 Plasma exchange in the management of homozygous familial hypercholesterolemia Lancet 1 1208-11
7. Klingel R, et al. 2003 From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis Ther. Apher. Dial. 7 350-8
8. Blessing F, et al. 2004 Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease Trans. Apher. Sci. 30 255-66
9. Ritter M M and Parhofer K G 2003 Extracorporal low-density lipoprotein elimination by immunoadsorption Ther. Apher. Dial. 7 370-2
10. Sato Y and Agishi T 1996 Low-density lipoprotein adsorption for arteriosclerotic patients Artif. Organs 20 324-7
11. Bosch T, et al. 1997 LDL hemoperfusion-a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood Artif. Organs 21 977-82
12. Mabuchi H, et al. 1987 A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis) Atherosclerosis 68 19-25
13. Mabuchi H, et al. 1998 Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia Am. J. Cardiol. 82 1489-95
14. Asahi T, Yamamoto T and Kutsuki H 2003 Blood purification therapies using dextran sulfate cellulose columns liposorber and selesorb Ther. Apher. Dial. 7 73-7
15. Otto C, et al. 2003 Efficacy and safety of a whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia Artif. Organs 27 1116-22
16. Otto C, et al. 2007 Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia J. Clin. Apher. 22 301-5
17. Bosch T 1996 Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results Artif. Organs 20 344-5
18. Wendler T, et al. 2000 Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility Int. J. Artif. Organs 23 710-7
19. Bosch T, et al. 2000 DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood Artif. Organs 24 81-90
20. Bosch T and Keller C 2003 Clinical effect of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction Ther. Apher. Dial. 7 341-4
21. Bosch T 2004 Practical aspect of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis Transfus. Apher. Sci. 31 83-8
22. Li H T, et al. 2004 Synthesis and adsorption aspect of crosslinked PVA-based blood compatible adsorbents for LDL apheresis React. Funct. Polym. 58 53-63
23. He B L and Huang W Q 1995 Ion Exchange and Adsorption Resins (Shanghai: Shanghai Press) pp 136-42
24. Wang Y, et al. 2004 Preparation and characterization of high loading porous crosslinked poly(vinyl alcohol) resins Polymer 45 71-7
25. Fang H, Wei J and Yu Y T 2004 In vivo studies of endotoxin removal by lysine-cellulose adsorbents Biomaterials 25 5433-40
26. Kobayashi A, et al. 2002 In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion Ther. Apher. 6 365-71
27. Cheng Y, et al. 2003 In vitro, in vivo studies of a new amphiphilic adsorbent for the removal of low-density lipoprotein Biomaterials 24 2189-94
28. Jia L Y, Guo R and Zhang X O 2005 Synthesis and characterization of novel adsorbents with different ligand composition for bilirubin conjugated with albumin Sep. Sci. Technol. 40 1387-99
29. Gao B J, et al. 2007 Studies on preparing and adsorption property of grafting terpolymer microbeads of PEI-GMA/AM/MBA for bilirubin J. Chromatogr. B 853 62-9
30. Uzun L and Denizli A 2006 Bilirubin removal performance of immobilized albumin in a magnetically stabilized fluidized bed J. Biomater. Sci. Polym. Edn 17 791-806
31. Stampfer M J, et al. 1996 A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction JAMA 276 882-8
32. Soltys P J and Etzel M R 2000 Equilibrium adsorption of LDL and gold immunoconjugates to affinity membranes containing PEG spacers Biomaterials 21 37-48
33. Denizli A 2002 Preparation of immuno-affinity membranes for cholesterol removal from human plasma J. Chromatogr. B 772 357-67
34. Ma K W, et al. 2008 Preparation of heparin-immobilized PVA and its adsorption for low-density lipoprotein from hyperlipemia plasma J. Mater. Sci. Mater. Med. 19 3255-61
35. Wang S Q, et al. 2003 A novel amphiphilic adsorbent for the removal of low-density lipoprotein Biomaterials 24 2799-802
36. Yu H F, et al. 2006 Synthesis and in vitro sorption properties of PAA-grafted cellulose beads for selective binding of LDL Artif. Cells Blood Substit. Immobil. Biotechnol. 34 501-13